Australian National University's Professor Chris Goodnow will test the controversial theory that autoimmune diseases may be caused by similar genetic mutations as benign lymphoma cancer after being awarded the $80,000 GlaxoSmithKline Award for Research Excellence.
The first stage of the research will involve patients with two particular autoimmune diseases, systemic lupus and Sjogren's syndrome.